ENvue Medical (FEED) Share-based Compensation Growth (1y) (2015 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -99.93% |
| Sep 30, 2024 | -22.22% |
| Jun 30, 2024 | -99.96% |
| Mar 31, 2024 | 59.70% |
| Dec 31, 2023 | -17.21% |
| Sep 30, 2023 | -68.97% |
| Jun 30, 2023 | -70.00% |
| Mar 31, 2023 | -22.09% |
| Dec 31, 2022 | 131,882.46% |
| Sep 30, 2022 | 17.17% |
| Jun 30, 2022 | 122.22% |
| Mar 31, 2022 | -21.10% |
| Dec 31, 2021 | 436.00% |
| Sep 30, 2021 | -45.90% |
| Jun 30, 2021 | 37.50% |
| Mar 31, 2021 | 53.52% |
| Dec 31, 2020 | -95.97% |
| Sep 30, 2020 | 66.36% |
| Jun 30, 2020 | -35.14% |
| Mar 31, 2020 | -94.68% |
| Dec 31, 2019 | 456.50% |
| Sep 30, 2019 | -77.91% |
| Jun 30, 2019 | 85.00% |
| Mar 31, 2019 | 1,124.77% |
| Dec 31, 2018 | 90.60% |
| Sep 30, 2018 | 238.78% |
| Jun 30, 2018 | -67.57% |
| Mar 31, 2018 | -68.95% |
| Dec 31, 2017 | -47.77% |
| Sep 30, 2017 | -9.82% |
| Jun 30, 2017 | 184.62% |
| Mar 31, 2017 | 440.00% |
| Dec 31, 2016 | 234.33% |
| Sep 30, 2016 | 126.39% |
| Jun 30, 2016 | -8.45% |
| Mar 31, 2016 | 550.00% |
| Dec 31, 2015 | 570.00% |
| Sep 30, 2015 | 1,700.00% |
| Jun 30, 2015 | 914.29% |
| Mar 31, 2015 | 233.33% |